Tag: health
-
Nearly 21 Million in US Have Substance Use Disorder: Surgeon General’s Report
Only one in 10 people getting help for substance use disorder.
-
New guidelines: Introduce peanuts to infants early to prevent allergies
By Rob Goodier (Reuters Health) – Parents may be able to reduce the chance that their children will develop peanut allergies by introducing the food early on, as young as four to six months of age, experts now say. The timing and method should depend on the infant’s risk of a peanut allergy, according to…
-
New guidelines: Introduce peanuts to infants early to prevent allergies
By Rob Goodier (Reuters Health) – Parents may be able to reduce the chance that their children will develop peanut allergies by introducing the food early on, as young as four to six months of age, experts now say. The timing and method should depend on the infant’s risk of a peanut allergy, according to…
-
AbbVie’s hepatitis C treatment shows promise
(Reuters) – Drugmaker AbbVie Inc said on Friday its experimental fixed-dose combination to treat certain hepatitis C virus patients achieved high sustained viral response (SVR) rates after eight weeks of treatment. The once-daily fixed-dose combination, glecaprevir/pibrentasvir (G/P), was given to HCV patients without cirrhosis and who were new to treatment in three different studies. About…
-
Mosul families squat in squalor between frontline and camps
By John Davison SHAHREZAD, Iraq (Reuters) – At the small mosque in Shahrezad village, piles of human faeces dot the toilets and rubbish is strewn around the garden. Fifty people are crammed into an abandoned and bombed-out home nearby, screening off its rooms with sheets for privacy, two days after fleeing fighting in Mosul for…
-
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain’s National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following…
-
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain’s National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following…
-
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources
By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) – U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. A Pfizer exit from the consumer health business, which includes…